The third podcast in this series features Londi Maduro, a film maker in California. Her film The Silent Killer: Prostate Cancer in the African American Community explores the myths, fears, and concerns about the disease. It follows several men who are all battling prostate cancer, focusing on how they’re dealing with their diagnoses, what treatment they decided to pursue, and how the disease has affected their lives.
The second podcast in “Disparities, Awareness, and Access to Health Care in the African America community“ features Mark Kennedy from the Boston Public Health Commission and Dr. Jacques Carter from Beth Israel Lahey and a member of the MPCC Medical Advisory Committee as they discuss how government institutions and health care organizations can work together with patients, families and organizations like MPCC to create more favorable outcomes in prostate cancer diagnosis, treatment and longevity.
The first in a three-part series on “Disparities, Awareness, and Access to Health Care in the African American Community” features Archie Emmanuel Jr, Lamont Scott, and Brother Al from MOCHA (Men of Color Health Awareness) located in Springfield, Massachusetts. Listen to their own personal stories on the importance of prostate cancer awareness as well as the learning more about the services that MOCHA and its collaborators provide.
Thanks to Dr. Karen E. Knudsen, CEO of the American Cancer Society, for joining the MPCC podcast series, Prostate Cancer & You. In this interview. She provides an outstanding overview of ACS and the latest thinking and activities that she and her colleagues are undertaking with regard to prostate cancer.
In this sixth episode, Michael A. DiSpezio discusses Kegels (aka pelvic floor exercises) and their role in regaining urinary continence. Then, he takes a deeper dive into shared decision making, and why it is essential for all patients to be an active part of this critical process. Michael discusses the advantages of focal therapy (not appropriate for all) as he describes several ablation treatments including ultra-cold temperatures and a relatively new therapeutic option known as HIFU. Michael presents the difficulty in predicting disease progression and response to treatment. He concludes the series referencing the statistics that not only illustrate prostate cancer’s high survival rates, but also highlights the advantage to uncovering the cancer before it has spread to distant sites.
In this fifth episode, Michael A. DiSpezio discusses the quality of life and how it changed following radical prostatectomy. Michael explains the basic difference between external beam radiation and the implantation of radioactive seeds, what radiation does, and addresses the side effects associated with this type of treatment. He introduces hormone therapy and how it is sometimes used alongside of radiation treatment as a therapy for returning cancer. Michael concludes this podcast by profiling the importance of support groups and options available.
In this fourth episode, Michael A. DiSpezio addresses the first PSA test following surgery and what that means as far as the tumor’s spread. He then presents the basics of cancer in terms of cells and DNA. Then, Michael discusses the likelihood of a man getting prostate cancer and how this disease disproportionately impacts African American men. In addition, he explains why prostate illnesses are also a concern for transwomen. Next, he addresses the DRE, short for digital rectal exam. Finally, Michael concludes this segment with a critical explanation of Gleason patterns, Gleason score and the Gleason grade groups.
In this third episode, Michael addresses the concept of quality of life and how one’s choice of treatment impacts the future. He profiles his own challenges with post-operative side effects including urinary incontinence, bowel issues, erectile dysfunction and the emotional turmoil associated with treatments. He addresses the surgical pathology report and how the results are interpreted in terms of cancer’s spread and if indicated, further treatment. He concludes this segment addressing challenges in depression and his return to a normal life.
In this second episode, Michael presents the basics of decision making as it pertains to critical choices he faced, including selecting the type of prostate biopsy. He explains what is communicated in a biopsy pathology report. In addition, Michael introduces us to a radical prostatectomy using a robotic-assisted procedure, along with the reported advantages of high-volume surgeons. He concludes this segment addressing bone scans, and their use in uncovering the spread of prostate cancer.
In this first episode, Michael introduces us to his personal journey with prostate cancer. It begins with addressing PSA and the role of this tumor marker in risk assessment for prostate cancer. He discusses active surveillance as a treatment option, family history, symptoms (and in his case, a lack of symptoms), and the need to expand one’s health care team to include a urologist. He concludes this segment with introducing the MRI fusion-guided biopsy.